-
-
-
-
-
-
-
BioCryst Announces Preliminary Full Year 2025 ORLADEYO® (berotralstat) Net Revenue of $601 Million (+37 percent y-o-y), Beating Prior Guidance Range
-
-
-
-
-
-
-
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
BioCryst names Charlie Gayer as next CEO after Jon Stonehouse retires
-
-
-
-
-
-
-
BioCryst Reports Fourth Quarter and Full Year 2019 Financial Results and Upcoming Key Milestones
-
-
-
-
-
-
-
Pre-Open Movers 05/21: (CIR) (ARWR) (PII) Higher; (BCRX) (MNK) (OCUL) (more...)
-
-
-
-
-
-
-
BioCryst (BCRX) Seen as Undervalued Pure-Play Late-Stage Orphan Co. - RBC
-
-
-
-
-
-
-
BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

